Company intelligence / Profile preview

IMA Life

Ownership: Private
Development stage: Commercial

Overview

IMA Life is a global leader in the design and manufacture of advanced aseptic processing lines and freeze-drying solutions used by major pharmaceutical companies worldwide. The division offers comprehensive product portfolios supporting liquid/powder filling in both aseptic/nonaseptic environments, lyophilization/freeze drying at all scales, gloveless ATMP/cell therapy production solutions, decontamination/isolation technologies, serialization-ready packaging equipment, as well as assembly/labelling machines. Its technologies are widely adopted across the industry but it does not itself conduct clinical trials or have drug candidates.

Industry: Therapeutic Medical Devices

Partnerships

Rheavita NV – strategic partnership on advanced freeze-drying/lyophilization tech development/commercial growth

Beyond the preview

Go deeper on IMA Life.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IMA Life.

Explore the full profile